Compound Detail
CHEMBL4457566
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1cc(C(=O)NC(C)(C)C)cc(C#Cc2ccc3c4c(oc3c2)C(C)(C)c2cc(NS(C)(=O)=O)ccc2C4=O)n1
Basic Information
| ChEMBL ID | CHEMBL4457566 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DCGOHGQJHJXBGW-UHFFFAOYSA-N |
5
Targets
9
Activities
1
Assay Types
12
PK Parameters
20
Publications
0
Known Names
Molecular Properties
569.7
MW (Da)
5.31
ALogP
6
HBA
2
HBD
118.4
PSA (Ų)
0.32
QED
2
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 9 meas. best 9.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| High affinity nerve growth factor receptor CHEMBL2815 | IC50 | 9.17 | 7.902 | 0.7 | 5 |
| BDNF/NT-3 growth factors receptor CHEMBL4898 | IC50 | 8.7 | 8.7 | 2.0 | 1 |
| NT-3 growth factor receptor CHEMBL5608 | IC50 | 8.55 | 8.55 | 2.8 | 1 |
| NIH3T3 CHEMBL614822 | IC50 | 8.08 | 8.08 | 8.4 | 1 |
| Tyrosine-protein kinase Lck CHEMBL258 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 5950.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 11000.0 | ng.hr.mL-1 | Canis lupus familiaris |
| CL | 1.07 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 1.48 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 1019.87 | nM | Rattus norvegicus |
| Cmax | 1339.35 | nM | Canis lupus familiaris |
| F | 38.0 | % | Rattus norvegicus |
| F | 97.5 | % | Canis lupus familiaris |
| T1/2 | 9.01 | hr | Rattus norvegicus |
| T1/2 | 15.2 | hr | Canis lupus familiaris |
| T1/2 | 7.49 | hr | Rattus norvegicus |
| T1/2 | 12.7 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36066182 | 10.1021/acs.jmedchem.2c01099 | ADMET | 15 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | NIH3T3 | 7 |
| 31444087 | 10.1016/j.bmcl.2019.126624 | High affinity nerve growth factor receptor | 3 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Cytochrome P450 3A4 | 2 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Insulin receptor | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Protein kinase C alpha type | 1 |
| 35617855 | 10.1016/j.ejmech.2022.114451 | High affinity nerve growth factor receptor | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Serine/threonine-protein kinase Chk1 | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Cyclin-dependent kinase 1 | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | RAC-alpha serine/threonine-protein kinase | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Hepatocyte growth factor receptor | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Tyrosine-protein kinase JAK2 | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Receptor tyrosine-protein kinase erbB-2 | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Fibroblast growth factor receptor 2 | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Epidermal growth factor receptor | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | ALK tyrosine kinase receptor | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | Vascular endothelial growth factor receptor 2 | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | NT-3 growth factor receptor | 1 |
| 36066182 | 10.1021/acs.jmedchem.2c01099 | BDNF/NT-3 growth factors receptor | 1 |
Data from ChEMBL 36 via Core Engine